Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating abemaciclib in combination with temozolomide versus temozolomide alone for pediatric and young adult high-grade glioma after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)
  • VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Glioma | Phase 2 | Status: ACTIVE_NOT_RECRUITING